Evidence map›Paper›PMID 34089302›Full record

ArticleCancer reports (Hoboken, N.J.)2022

A case report of prostate cancer with leptomeningeal metastasis.

Mansoureh Dehghani, Babak PeyroShabany, Ramin Shahraini, Danial Fazilat-Panah, Fateme Hashemi, James S Welsh, Seyed Alireza Javadinia

Open access · goldAbstract readCase Reports
In one paragraph

Article in Cancer reports (Hoboken, N.J.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Mansoureh DehghaniCancer Research Centre, Mashhad University of Medical Sciences, Mashhad, Iran.ORCID 0000-0001-8670-8525
Babak PeyroShabanyDepartment of Internal Medicine, School of Medicine, Sabzevar University of Medical Sciences, Sabzevar, Iran.ORCID 0000-0002-4452-2041
Ramin ShahrainiDepartment of Radiology, School of Medicine, Sabzevar University of Medical Sciences, Sabzevar, Iran.ORCID 0000-0002-3854-7429
Danial Fazilat-PanahCancer Research Center, Babol University of Medical Sciences, Babol, Iran.ORCID 0000-0003-4194-6575
Fateme HashemiDepartment of Internal Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
James S WelshEdward Hines Jr VA Hospital and Loyola University Chicago Stritch School of Medicine, Chicago, Illinois, USA.ORCID 0000-0002-3255-6412
Seyed Alireza JavadiniaCellular and Molecular Research Center, Sabzevar University of Medical Sciences, Sabzevar, Iran.ORCID 0000-0003-2467-837X
Sabzevar University of Medical Sciences · IRMashhad University of Medical Sciences · IRBabol University of Medical Sciences · IRLoyola University Chicago · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundProstate cancer is the most prevalent cancer in men. However, leptomeningeal involvement by prostate carcinoma is a rare event. CASE: Here, we report a 69-year-old patient with castration-resistant metastatic prostate cancer who presented with headache and ataxia. Brain MRI revealed a huge invasive interaxial mass at right occipital lobe with diffuse thickening and enhancement of meninges, the arachnoid, and the pia mater, and he was diagnosed with leptomeningeal carcinomatosis. The patient received whole brain radiotherapy.

conclusionDespite the fact that brain and leptomeningeal metastases are not very common in patients with prostate cancer, signs and symptoms of nervous system disorders should be assessed carefully, and consideration of such unusual metastases must be considered.

Indexed as

Meningeal CarcinomatosisProstatic NeoplasmsAgedArachnoidHumansMagnetic Resonance ImagingMalePia Materleptomeningeal carcinomatosisprostate cancer

Identifiers

PMID34089302
PMCPMC9351675
OpenAlexW3165033119

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.